Treatment discharge is not the finish line. It is a transfer point.
The first days after residential, inpatient, PHP, or IOP care can carry avoidable risk. Medications may run out. Appointments may be scheduled too far away. Transportation may fail. The home environment may be unchanged. Reduced opioid tolerance can make a return to use especially dangerous.
A continuing-care plan turns “aftercare” into named appointments, people, medications, addresses, and backup actions.
Discharge checklist
- First clinical appointment has a date, time, location, and confirmed provider
- Addiction and psychiatric medications are reconciled
- Prescriptions are filled or available through the next prescriber visit
- Naloxone is provided or obtained when opioid exposure is possible
- Transportation is arranged
- Housing is confirmed and safety has been considered
- Recovery support meetings or peer contacts are identified if desired
- Work, school, and caregiving plans are realistic
- Family members understand boundaries and emergency steps
- Warning signs and a recurrence response are written down
- Emergency, crisis, and after-hours contacts are saved
- Consent forms allow necessary provider communication
The first appointment should already exist
“Call this clinic” leaves the highest-friction step for the moment when the person may have the least capacity to complete it. Whenever possible, the discharging team should help secure the first appointment and transfer needed records with consent.
The follow-up level might be residential, PHP, IOP, standard outpatient care, addiction medicine, psychiatry, primary care, or a combination across the full continuum of levels of care.
Protect medication continuity
Before discharge, compare the medication list with what the next clinician expects. Confirm doses, pharmacy, prior authorization, remaining supply, and who answers questions after hours.
For opioid use disorder, interruption of methadone or buprenorphine can create serious risk. For psychiatric medications prescribed as part of treatment for co-occurring disorders, abrupt changes can also cause withdrawal or symptom return. Do not stop or change medication without guidance from the prescribing clinician.
Decide where the person will live
Home may be supportive, neutral, or actively unsafe. Consider substance availability, violence, conflict, isolation, transportation, and whether other residents support the plan.
Recovery housing may be useful for some people, but it is not the same as licensed treatment. Ask about fees, rules, medication policies, drug testing, staff coverage, transportation, ownership ties to clinical providers, and what happens if clinical coverage ends.
Peer support is one layer
Mutual-help and peer recovery groups can add community, routine, and practical support. Options differ in philosophy and format. They are not replacements for needed medical or psychiatric care.
The useful plan is specific: which meeting, which day, how the person will get there, and whom they will contact if they do not go.
Family support needs boundaries
Families often leave treatment with broad instructions to “be supportive.” That is not operational.
Clarify who will store naloxone, help with transportation, attend family sessions, protect children, secure medications, or respond to a missed appointment. Also clarify what family members will not do, such as provide cash, conceal dangerous behavior, or assume the role of clinician.
Return to work or school gradually when possible
The calendar should account for appointments, fatigue, medication adjustments, transportation, and the stress of reentry. A person may need workplace accommodations or a phased return. Privacy decisions belong to the individual, within applicable legal and safety constraints.
Plan for recurrence before it happens
A return to use should trigger action, not secrecy or moral judgment. The written response might include contacting the treatment team, obtaining an urgent assessment, moving temporarily to a safer setting, increasing visit frequency, or stepping up care.
Overdose prevention is essential. Reduced tolerance can increase risk. Naloxone should be available when opioid exposure is possible, including potential fentanyl contamination.
Emergency contacts
- Medical emergency or immediate danger: 911
- Mental health or suicide crisis in the United States: Call or text 988
- Poison Control in the United States: 1-800-222-1222
- SAMHSA National Helpline: 1-800-662-HELP (4357)
Next step
Before discharge, ask to review the plan line by line. If a box depends on the person making a call later, ask whether it can be completed now. Our guide to how to choose an addiction treatment program covers the same questions before admission.
Sources
- NIDA, Principles of Drug Addiction Treatment
- NIDA, Treatment and Recovery
- CDC, Lifesaving Naloxone
- SAMHSA, Find Support
Medical disclaimer: General education only. Follow the discharge instructions and medication guidance provided by licensed clinicians. Call 911 for an overdose, severe withdrawal, or immediate danger; call or text 988 in the United States for a mental health or suicide crisis.
Frequently asked questions
Is aftercare always outpatient therapy?
No. Continuing care may include medication, a higher or lower clinical level, primary care, psychiatry, recovery housing, peer support, family work, and practical services.
What if the recommended program has a waiting list?
Ask the discharging team for an interim plan: bridge medication, earlier clinical contact, alternative providers, transportation, safety monitoring, and a clear escalation pathway.
What if substance use returns?
Respond quickly. Overdose risk may be elevated after abstinence. Contact a clinician for reassessment, use naloxone for suspected opioid overdose, and call 911 for an emergency.